BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/5/2014 2:54:00 PM | Browse: 1285 | Download: 1608
Publication Name World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID 6539
Country United States
ISSN 2150-5349 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Histamine2-receptor antagonists: Rapid development of tachyphylaxis with repeat dosing
Manuscript Source Invited Manuscript
All Author List Johnson W McRorie, James A Kirby and Philip B Miner
Funding Agency and Grant Number
Corresponding Author Johnson W McRorie, PhD, FACG, AGAF, Quantitative Sciences, Procter and Gamble, 8700 Mason-Montgomery Road, Mason, OH 45040, United States. mcrorie.jw@pg.com
Key Words Histamine2-receptor antagonist; Tachyphylaxis; Tolerance; Gastric pH
Core Tip Histamine2-receptor antagonists (H2RAs) are available over-the-counter (OTC) for the treatment and prevention of heartburn, but recommendations for use should be limited to those with infrequent heartburn. A single dose of an H2RA can be effective for controlling gastric acid and preventing or relieving heartburn, but tolerance (tachyphylaxis) develops rapidly, and is evident by the second day/second dose. Even if symptom relief is achieved, it may be due to desensitization of the esophagus to acid by the H2RA, potentially providing symptom relief without significantly decreasing esophageal acid exposure. For frequent heartburn (≥ 2 d/wk), an OTC proton pump inhibitor should be considered.
Publish Date 2014-05-20 15:49
Citation McRorie JW, Kirby JA, Miner PB. Histamine2-receptor antagonists: Rapid development of tachyphylaxis with repeat dosing. World J Gastrointest Phar­macol Ther 2014; 5(2): 57-62
URL http://www.wjgnet.com/2150-5349/full/v5/i2/57.htm
DOI http://dx.doi.org/10.4292/wjgpt.v5.i2.57
Full Article (PDF) WJGPT-5-57.pdf
Full Article (Word) WJGPT-5-57.doc